752 related articles for article (PubMed ID: 19278532)
1. The economic impact of overactive bladder syndrome in six Western countries.
Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
[TBL] [Abstract][Full Text] [Related]
2. The current and future burden and cost of overactive bladder in five European countries.
Reeves P; Irwin D; Kelleher C; Milsom I; Kopp Z; Calvert N; Lloyd A
Eur Urol; 2006 Nov; 50(5):1050-7. PubMed ID: 16753252
[TBL] [Abstract][Full Text] [Related]
3. The economic costs of overactive bladder in Germany.
Klotz T; Brüggenjürgen B; Burkart M; Resch A
Eur Urol; 2007 Jun; 51(6):1654-62; discussion 1662-3. PubMed ID: 17161521
[TBL] [Abstract][Full Text] [Related]
4. The total economic burden of overactive bladder in the United States: a disease-specific approach.
Onukwugha E; Zuckerman IH; McNally D; Coyne KS; Vats V; Mullins CD
Am J Manag Care; 2009 Mar; 15(4 Suppl):S90-7. PubMed ID: 19355803
[TBL] [Abstract][Full Text] [Related]
5. Estimated cost of overactive bladder in Thailand.
Prasopsanti K; Santi-Ngamkun A; Pornprasit K
J Med Assoc Thai; 2007 Nov; 90(11):2316-20. PubMed ID: 18181313
[TBL] [Abstract][Full Text] [Related]
6. Economic costs of overactive bladder in the United States.
Ganz ML; Smalarz AM; Krupski TL; Anger JT; Hu JC; Wittrup-Jensen KU; Pashos CL
Urology; 2010 Mar; 75(3):526-32, 532.e1-18. PubMed ID: 20035977
[TBL] [Abstract][Full Text] [Related]
7. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
8. Lower urinary tract symptoms in women.
Milsom I
Curr Opin Urol; 2009 Jul; 19(4):337-41. PubMed ID: 19444118
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of urgency urinary incontinence in the United States: a systematic review.
Coyne KS; Wein A; Nicholson S; Kvasz M; Chen CI; Milsom I
J Manag Care Pharm; 2014 Feb; 20(2):130-40. PubMed ID: 24456314
[TBL] [Abstract][Full Text] [Related]
10. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
11. The burden of prenatal exposure to alcohol: revised measurement of cost.
Stade B; Ali A; Bennett D; Campbell D; Johnston M; Lens C; Tran S; Koren G
Can J Clin Pharmacol; 2009; 16(1):e91-102. PubMed ID: 19168935
[TBL] [Abstract][Full Text] [Related]
12. Costs of urinary incontinence and overactive bladder in the United States: a comparative study.
Hu TW; Wagner TH; Bentkover JD; Leblanc K; Zhou SZ; Hunt T
Urology; 2004 Mar; 63(3):461-5. PubMed ID: 15028438
[TBL] [Abstract][Full Text] [Related]
13. Economic considerations in overactive bladder.
Hu TW; Wagner TH
Am J Manag Care; 2000 Jul; 6(11 Suppl):S591-8. PubMed ID: 11183902
[TBL] [Abstract][Full Text] [Related]
14. Acute coronary syndromes in Europe: 1-year costs and outcomes.
Taylor MJ; Scuffham PA; McCollam PL; Newby DE
Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
[TBL] [Abstract][Full Text] [Related]
15. Health-related consequences of overactive bladder: an economic perspective.
Hu TW; Wagner TH
BJU Int; 2005 Sep; 96 Suppl 1():43-5. PubMed ID: 16086679
[TBL] [Abstract][Full Text] [Related]
16. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries.
Irwin DE; Milsom I; Kopp Z; Abrams P; Cardozo L
BJU Int; 2006 Jan; 97(1):96-100. PubMed ID: 16336336
[TBL] [Abstract][Full Text] [Related]
17. Health-related consequences of overactive bladder.
Wagner TH; Hu TW; Bentkover J; LeBlanc K; Stewart W; Corey R; Zhou Z; Hunt T
Am J Manag Care; 2002 Dec; 8(19 Suppl):S598-607. PubMed ID: 12516954
[TBL] [Abstract][Full Text] [Related]
18. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
[TBL] [Abstract][Full Text] [Related]
19. Estimating the cost of epilepsy in Europe: a review with economic modeling.
Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
[TBL] [Abstract][Full Text] [Related]
20. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
